Cimpress N.V. (CMPR) Tops Q2 EPS by 50c

Cimpress N.V. (NASDAQ: CMPR) reported Q2 EPS of $2.12, $0.50 better than the analyst estimate of $1.62. Revenue for the quarter came in at $439.9 million versus the consensus estimate of $431.62 million.

For earnings history and earnings-related data on Cimpress N.V. (CMPR) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c